Literature DB >> 26483174

In utero stem cell transplantation and gene therapy: Recent progress and the potential for clinical application.

Lauren E McClain1, Alan W Flake2.   

Abstract

Advances in prenatal diagnosis have led to the prenatal management and treatment of a variety of congenital diseases. Although surgical treatment has been successfully applied to specific anatomic defects that place the fetus at a risk of death or life-long disability, the indications for fetal surgical intervention have remained relatively limited. By contrast, prenatal stem cell and gene therapy await clinical application, but they have tremendous potential to treat a broad range of genetic disorders. If there are biological advantages unique to fetal development that favor fetal stem cell or gene therapy over postnatal treatment, prenatal therapy may become the preferred approach to the treatment of any disease that can be prenatally diagnosed and cured by stem cell or gene therapy. Here, we review the field including recent progress toward clinical application and imminent clinical trials for cellular and gene therapy.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  gene therapy; hematopoietic stem cell transplantation; in utero; prenatal therapy

Mesh:

Year:  2015        PMID: 26483174     DOI: 10.1016/j.bpobgyn.2015.08.006

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  18 in total

1.  Foetal surgery and using in utero therapies to reduce the degree of disability after birth. Could it be morally defensible or even morally required?

Authors:  Constantinos Kanaris
Journal:  Med Health Care Philos       Date:  2017-03

2.  Pre-Existing Maternal Antibodies Cause Rapid Prenatal Rejection of Allotransplants in the Mouse Model of In Utero Hematopoietic Cell Transplantation.

Authors:  John S Riley; Lauren E McClain; John D Stratigis; Barbara E Coons; Haiying Li; Heather A Hartman; William H Peranteau
Journal:  J Immunol       Date:  2018-07-18       Impact factor: 5.422

3.  Investigating Optimal Autologous Cellular Platforms for Prenatal or Perinatal Factor VIII Delivery to Treat Hemophilia A.

Authors:  Christopher Stem; Christopher Rodman; Ritu M Ramamurthy; Sunil George; Diane Meares; Andrew Farland; Anthony Atala; Christopher B Doering; H Trent Spencer; Christopher D Porada; Graça Almeida-Porada
Journal:  Front Cell Dev Biol       Date:  2021-08-10

4.  Therapeutic potential of adenovirus-encoding brain-derived neurotrophic factor for spina bifida aperta by intra-amniotic delivery in a rat model.

Authors:  Wei Ma; Xiaowei Wei; Hui Gu; Dan Liu; Wenting Luo; Dong An; Yuzuo Bai; Zhengwei Yuan
Journal:  Gene Ther       Date:  2020-02-24       Impact factor: 5.250

5.  Regulatory T cells promote alloengraftment in a model of late-gestation in utero hematopoietic cell transplantation.

Authors:  John S Riley; Lauren E McClain; John D Stratigis; Barbara E Coons; Nicholas J Ahn; Haiying Li; Stavros P Loukogeorgakis; Camila G Fachin; Andre I B S Dias; Alan W Flake; William H Peranteau
Journal:  Blood Adv       Date:  2020-03-24

Review 6.  Thalassemia: Common Clinical Queries in Management.

Authors:  Ashutosh Lal; Deepak Bansal
Journal:  Indian J Pediatr       Date:  2019-10-16       Impact factor: 1.967

Review 7.  Delivery technologies for in utero gene therapy.

Authors:  Rohan Palanki; William H Peranteau; Michael J Mitchell
Journal:  Adv Drug Deliv Rev       Date:  2020-11-09       Impact factor: 15.470

8.  A Novel Model of Fetal Spinal Cord Exposure Allowing for Long-Term Postnatal Survival.

Authors:  Sarah C Stokes; Jordan E Jackson; Christina M Theodorou; Christopher D Pivetti; Priyadarsini Kumar; Kaeli J Yamashiro; Aijun Wang; Diana L Farmer
Journal:  Fetal Diagn Ther       Date:  2021-06-10       Impact factor: 2.208

Review 9.  In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application.

Authors:  Graça Almeida-Porada; Anthony Atala; Christopher D Porada
Journal:  Mol Ther Methods Clin Dev       Date:  2016-03-30       Impact factor: 6.698

10.  A comparison of intrauterine hemopoietic cell transplantation and lentiviral gene transfer for the correction of severe β-thalassemia in a HbbTh3/+ murine model.

Authors:  Niraja M Dighe; Kang Wei Tan; Lay Geok Tan; Steven S W Shaw; Suzanne M K Buckley; Dedy Sandikin; Nuryanti Johana; Yi-Wan Tan; Arijit Biswas; Mahesh Choolani; Simon N Waddington; Michael N Antoniou; Jerry K Y Chan; Citra N Z Mattar
Journal:  Exp Hematol       Date:  2018-03-29       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.